Collectively, these results are consistent with the hypothesis that pharmacological block of NaV1.7 reduces sensitivity to noxious heat, phenotypically analogous to studies of NaV1.7 loss-of-function in CIP patients2. Here, SCN9A is linked to hereditary sensory and autonomic neuropathy.